CA
Corriente Advisors Portfolio holdings
AUM
$3.45M
This Quarter Return
-7.72%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$272M
AUM Growth
+$272M
(-35%)
Cap. Flow
-$117M
Cap. Flow
% of AUM
-43.19%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
23
New
4
Increased
5
Reduced
1
Closed
13
Top Buys
| 1 |
Teledyne Technologies
TDY
|
$22.8M |
| 2 |
Meta Platforms (Facebook)
META
|
$14.7M |
| 3 |
Lantern Pharma
LTRN
|
$12.9M |
| 4 |
Cue Biopharma
CUE
|
$7.73M |
| 5 |
Cardiff Oncology
CRDF
|
$7.27M |
Top Sells
| 1 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$64.9M |
| 2 |
Cameco
CCJ
|
$29.2M |
| 3 |
GoPro
GPRO
|
$27.7M |
| 4 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
$15.9M |
| 5 |
APTO
Aptose Biosciences, Inc.
APTO
|
$12.7M |
Sector Composition
| 1 | Healthcare | 49.3% |
| 2 | Technology | 45.28% |
| 3 | Communication Services | 5.42% |
| 4 | Consumer Discretionary | 0% |
| 5 | Energy | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MAXR
1
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
| $100M | 36.9% | 2,650,000 +150,000 | +6% | +$5.67M |
|
2
Replimune Group
REPL
$422M
| $32.8M | 12.08% | 1,075,000 -160,000 | -13% | -$4.88M |
|
|
3
Cue Biopharma
CUE
$60M
| $31.1M | 11.45% | 2,549,031 +633,812 | +33% | +$7.73M |
|
|
4
Cardiff Oncology
CRDF
$140M
| $25.8M | 9.5% | 2,785,410 +785,410 | +39% | +$7.27M |
|
|
5
Teledyne Technologies
TDY
$25.2B
| $22.8M | 8.38% | +55,000 | New | +$22.8M |
|
|
TFFP
6
DELISTED
TFF Pharmaceuticals, Inc. Common Stock
TFFP
| $21.2M | 7.82% | 1,565,682 +215,682 | +16% | +$2.93M |
|
|
7
Meta Platforms (Facebook)
META
$1.86T
| $14.7M | 5.42% | +50,000 | New | +$14.7M |
|
|
8
Lantern Pharma
LTRN
$44.1M
| $12.9M | 4.77% | +713,806 | New | +$12.9M |
|
9
DiaMedica Therapeutics
DMAC
$295M
| $7.96M | 2.93% | 870,228 +63,328 | +8% | +$579K |
|
10
EyePoint Pharmaceuticals
EYPT
$797M
| $2.03M | 0.75% | +200,000 | New | +$2.03M |
|
|
11
GoPro
GPRO
$247M
| – | – | -3,350,000 | Closed | -$27.7M |
|
12
Kratos Defense & Security Solutions
KTOS
$11.1B
| – | – | -200,014 | Closed | -$5.49M |
|
13
NexGen Energy
NXE
$4.5B
| – | – | -1,000,000 | Closed | -$2.76M |
|
14
Ocular Therapeutix
OCUL
$2.12B
| – | – | -53,934 | Closed | -$1.12M |
|
15
QuantumScape
QS
$4.49B
| – | – | -1,000 | Closed | -$84K |
|
|
RETA
16
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| – | – | -525,000 | Closed | -$64.9M |
|
|
ONCR
17
DELISTED
Oncorus, Inc.
ONCR
| – | – | -78,043 | Closed | -$2.52M |
|
|
APTO
18
DELISTED
Aptose Biosciences, Inc.
APTO
| – | – | -2,900,000 | Closed | -$12.7M |
|
|
CNCE
19
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – | -680,000 | Closed | -$8.6M |
|
|
MNDT
20
DELISTED
Mandiant, Inc. Common Stock
MNDT
| – | – | -690,000 | Closed | -$15.9M |
|
|
21
Cameco
CCJ
$33.7B
| – | – | -2,177,086 | Closed | -$29.2M |
|
|
CMPS
22
Compass Pathways
CMPS
$424M
| – | – | -190,000 | Closed | -$9.05M |
|
23
Curis
CRIS
$20.9M
| – | – | -1,100,000 | Closed | -$9.01M |
|